Related Experiment Video

Updated: Apr 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy

Elion Hoxha1, Sigrid Harendza1, Hans Pinnschmidt2

  • 1III. Department of Internal Medicine and.

Clinical Journal of the American Society of Nephrology : CJASN
|October 1, 2014
PubMed
Abstract

Insights

High levels of M-type phospholipase A2 receptor autoantibodies predict faster kidney function decline in primary membranous nephropathy patients. This finding may aid in treatment decisions for kidney disease progression.

Area of Science:

  • Nephrology
  • Immunology

Background:

  • Primary membranous nephropathy (MN) progression is difficult to predict using standard markers.
  • M-type phospholipase A2 receptor (MPR) autoantibodies are linked to proteinuria but their impact on renal function is unclear.

Purpose of the Study:

  • To investigate the association between MPR autoantibody levels and the rate of renal function decline in patients with MN.
  • To determine if MPR autoantibody levels can predict an increase in serum creatinine.

Main Methods:

  • Prospective, open, multicenter study of 118 MN patients with positive MPR autoantibodies.
  • Patients were stratified into tertiles based on MPR autoantibody levels (low, medium, high).
  • Clinical endpoint: serum creatinine increase ≥ 25% and reaching ≥ 1.3 mg/dl over a median follow-up of 27 months.

Main Results:

  • High MPR autoantibody levels (tertile 3) were associated with reaching the endpoint in 69% of patients, versus 25% in the low level group (tertile 1).
  • The average time to reach the endpoint was significantly shorter in the high MPR autoantibody group (17.7 months) compared to the low group (30.9 months).
  • Multivariate analysis identified high MPR autoantibody levels, male sex, and older age as independent predictors of progressive renal function loss.

Conclusions:

  • Elevated MPR autoantibody levels are linked to a more rapid decline in kidney function in primary MN.
  • MPR autoantibody levels may serve as a valuable biomarker for predicting disease progression and guiding treatment strategies in MN.
Keywords:
membranous nephropathynephrotic syndromerenal function declinerisk factors

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.6K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.1K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
403
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
24
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.1K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
4